Blood Test for Colon Cancer: Panacea or Hype? (Medpage Today)

Aasma Shaukat, MD, MPH discusses the challenges of low colorectal cancer (CRC) screening rates in the U.S., despite the availability of effective methods like colonoscopy and stool-based tests. She highlights the recent FDA approval of a blood test for CRC screening, which may boost adherence due to its simplicity. However, there are concerns about its efficacy compared to traditional methods and its potential impact on existing screening practices. The article urges clinicians to consider the role of this new test in their practice.